| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.001 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |